IRADIMED CORPORATION (IRMD) News
Follow IRADIMED CORPORATION (IRMD) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
IRMD - IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
IRMD - IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
NEWS | Sep 23, 2026, 01:01 PM UTC
L
iRadimed Raises FY2026 Adj EPS Guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 Est; Raises FY2026 Sales Guidance from $91.000M-$96.000M to
iRadimed (NASDAQ: IRMD ) raises FY2026 Adj EPS guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 analyst estimate. Raises FY2026 sales outlook from $91.000 million-$96.000 million to $91.000 billion-$96.000 billion vs $9
EARNINGS | Jul 31, 2026, 12:16 PM UTC
L
IRMD Iradimed RESULTS: Q2, Q2 REV $20.5M, Q2 EPS $0.41
IRMD Iradimed RESULTS: Q2, Q2 REV $20.5M, Q2 EPS $0.41
EARNINGS | Jul 31, 2026, 12:15 PM UTC
L
IRMD - IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
IRMD - IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
EARNINGS | Jul 31, 2026, 12:15 PM UTC
L
Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline
Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline
EQUITY | Jul 27, 2026, 02:10 PM UTC